As of September 29, 2026, the three largest insider holders of OVID are Pharmaceutical Co Ltd Takeda (TenPercentOwner, 7.00Mn shares), Jeremy M Levin (Executive Chairman, 3.74Mn shares), Stelios Papadopoulos (Director, 217.58K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Pharmaceutical Co Ltd Takeda | TenPercentOwner | 0 | 7,000,000 | 7,000,000 | 61.7% | 09 Dec, 2025 |
| 2 | Jeremy M Levin | Executive Chairman | 3,735,048 | 0 | 3,735,048 | 32.9% | 25 Mar, 2026 |
| 3 | Stelios Papadopoulos | Director | 217,578 | 0 | 217,578 | 1.9% | 09 Apr, 2026 |
| 4 | Jeffrey A Rona | Cbfo | 156,313 | 0 | 156,313 | 1.4% | 02 Mar, 2026 |
| 5 | Charles Ross Carter | Chief Financial Officer | 94,375 | 0 | 94,375 | 0.8% | 08 Jul, 2026 |
| 6 | Margaret A. Alexander | President And Ceo | 61,750 | 0 | 61,750 | 0.5% | 02 Mar, 2026 |
| 7 | Thomas Michael Perone | General Counsel, Secretary | 28,125 | 0 | 28,125 | 0.2% | 26 Feb, 2024 |
| 8 | Jason Tardio | Chief Operating Officer | 28,125 | 0 | 28,125 | 0.2% | 26 Feb, 2024 |
| 9 | Kevin Joseph Fitzgerald | Director | 17,578 | 0 | 17,578 | 0.2% | 09 Apr, 2026 |
| 10 | Bart Friedman | Director | 8,789 | 0 | 8,789 | 0.1% | 09 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 06 Jul, 2026 | Charles Ross Carter | Chief Financial Officer | Acquired A | 50,000 | $0.00 | $0 | 94,375 | Direct |
| 15 Jun, 2026 | Anna Greka | Director | Acquired A | 130,000 | $0.00 | $0 | 130,000 | Direct |
| 07 Apr, 2026 | Stelios Papadopoulos | Director | Acquired A | 17,578 | $2.56 | $45.00K | 217,578 | Direct |
| 07 Apr, 2026 | Kevin Joseph Fitzgerald | Director | Acquired A | 17,578 | $2.56 | $45.00K | 17,578 | Direct |
| 07 Apr, 2026 | Bart Friedman | Director | Acquired A | 8,789 | $2.56 | $22.50K | 8,789 | Direct |
| 23 Mar, 2026 | Jeremy M Levin | Executive Chairman | Acquired M | 47,333 | $1.40 | $66.27K | 3,735,048 | Direct |
| 23 Mar, 2026 | Jeremy M Levin | Executive Chairman | Disposed M | 47,333 | $0.00 | $0 | 0 | Direct |
| 23 Feb, 2026 | Jeffrey A Rona | Cbfo | Disposed S | 8,541 | $1.45 | $12.38K | 88,188 | Direct |
| 26 Feb, 2026 | Bart Friedman | Director | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 26 Feb, 2026 | Barbara Gayle Duncan | Director | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 26 Feb, 2026 | Jeremy M Levin | Director | Acquired A | 957,000 | $0.00 | $0 | 957,000 | Direct |
| 23 Feb, 2026 | Margaret A. Alexander | President And Ceo | Disposed S | 11,656 | $1.45 | $16.90K | 61,750 | Direct |
| 26 Feb, 2026 | Kevin Joseph Fitzgerald | Director | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 26 Feb, 2026 | Stelios Papadopoulos | Director | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 26 Feb, 2026 | Karen Bernstein | Director | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 26 Feb, 2026 | Jeffrey A Rona | Cbfo | Acquired A | 68,125 | $0.00 | $0 | 156,313 | Direct |
| 26 Feb, 2026 | Margaret A. Alexander | President And Ceo | Acquired A | 1,435,000 | $0.00 | $0 | 1,435,000 | Direct |
| 26 Feb, 2026 | Jeffrey A Rona | Cbfo | Acquired A | 408,750 | $0.00 | $0 | 408,750 | Direct |
| 04 Jan, 2026 | Margaret A. Alexander | President And Ceo | Acquired A | 890,000 | $0.00 | $0 | 890,000 | Direct |
| 15 Dec, 2025 | Jeremy M Levin | Ceo | Acquired C | 71,000 | — | — | 3,687,715 | Direct |